Overview:

Medical device report: “Brazil Diabetes Care Devices Market Analysis and Forecasts to 2015” report provides key data, information and analysis on the Brazil diabetes care devices market. The report provides market landscape, competitive landscape and market trends information on two market categories - glucose monitoring and insulin delivery. The report provides comprehensive information on the key trends affecting these categories, and key analytical insight on the market dynamics. The report also reviews the competitive landscape in terms of mergers and acquisitions, pipeline products and technology offerings.

Scope

• Forecasts & Analysis of the Brazil diabetes care devices market to 2015.

• Market segmentation by glucose monitoring and insulin delivery. Glucose monitoring further segmented into blood glucose meters and blood glucose test strips. Insulin delivery further segmented into insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories.

• Market Analysis from 2001 to 2008, including new updated 2008 data.

• Analysis of the leading companies and competitive landscape including 2008 company market share analysis.

• Analysis of key diabetes care pipeline products, new technologies and clinical trials.

• Insight into the key mergers and acquisitions (M&As), partnerships, venture capital and private equity investments.

• Qualitative analysis of market drivers, market limiters regulatory issues and future outlook.

Reasons to buy

• Understand what the new growth opportunities are within the Brazil diabetes care devices market.

• Develop a clear knowledge & understanding of the Brazil diabetes care devices competitor landscape and how this will change to 2015.

• Identify acquisition opportunities across the Brazil diabetes care devices market.

• Identify key winners and losers and who is best positioned to take advantage of the emerging market opportunities.

• Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

3 Executive Summary

4 Definitions of Markets Covered in the Report

4.1 Diabetic Care Devices

4.2 Glucose Monitoring Devices

4.2.1 Blood Glucose Meters

4.2.2 Blood Glucose Strips

4.3 Insulin Delivery

4.3.1 Insulin Pens

4.3.2 Insulin Syringes

4.3.3 Insulin Pumps

4.3.4 Traditional Insulin Pump Accessories

5 Healthcare Sector Review

5.1 Healthcare Expenditure

5.2 Healthcare Infrastructure

5.3 Healthcare Policy

6 Regulation System

6.1 Medical Device Registration Protocol

6.1.1 Registration Documentation

6.1.2 Registration Procedure

6.1.3 Medical Device Registration Fee

7 Pricing and Reimbursement

8 Distribution Structure

9 Diabetes Care Devices In Brazil

9.1 Diabetes Care Devices, Brazil, Overall Revenue ($ m), 2000-2015

9.2 Diabetes Care Devices, Brazil, Category Volume (Units), 2000-2015

9.3 Diabetes Care Devices, Brazil, Cross-Category Analysis, 2000-2015

9.4 Diabetes Care Devices, Brazil, Company Share (2007-2008)

10 Glucose Monitoring In Brazil

10.1 Glucose Monitoring Overall Revenue (2000-2015)

10.2 Glucose Monitoring Overall Volume (2000-2015)

10.3 Glucose Monitoring Average Price (2000-2015)

10.4 Glucose Monitoring Market Dynamics

10.5 Glucose Monitoring Distribution Share (2007-2008)

10.6 Glucose Monitoring, Brazil, Company Share (2007-2008)

11 Insulin Delivery In Brazil

11.1 Insulin Delivery Overall Revenue (2000-2015)

11.1.1 Insulin Pens Overall Revenue (2000-2015)

11.2 Insulin Delivery Overall Volume (2000-2015)

11.2.1 Insulin Pens Overall Volume (2000-2015)

11.3 Insulin Delivery Average Price (2000-2015)

11.4 Insulin Delivery Market Dynamics

11.5 Insulin Delivery Distribution Share (2007-2008)

11.6 Insulin Delivery, Brazil, Company Share (2007-2008)

12 Overview of Key Companies in Brazil Diabetes Care Devices Market

12.1 F. Hoffmann-La Roche Ltd.

12.1.1 Company Overview

12.1.2 Value Chain Analysis

12.1.3 F. Hoffmann-La Roche Ltd Pipeline Products

12.2 LifeScan, Inc.

12.2.1 Company Overview

12.2.2 LifeScan, Inc. Pipeline Products

12.3 Abbott Laboratories

12.3.1 Company Overview

12.3.2 Value Chain Analysis

12.3.3 Abbott Laboratories Pipeline Products

12.4 Bayer HealthCare AG

12.4.1 Company Overview

12.4.2 Value Chain Analysis

12.4.3 Bayer HealthCare AG Pipeline Products

12.5 Becton, Dickinson and Company

12.5.1 Company Overview

12.5.2 Value Chain Analysis

12.6 Medtronic, Inc.

12.6.1 Company Overview

12.6.2 Value Chain Analysis

12.6.3 Medtronic, Inc. Pipeline Products

12.7 Eli Lilly and Company

12.7.1 Company Overview

12.7.2 Value Chain Analysis

12.7.3 Eli Lilly and Company Pipeline Products

12.8 Novo Nordisk A/S

12.8.1 Company Overview

12.8.2 Novo Nordisk A/S Pipeline Products

12.9 Terumo Corporation

12.9.1 Company Overview

12.9.2 Value Chain Analysis

12.10 Animas Corporation

12.10.1 Company Overview

12.11 Sanofi-Aventis

12.11.1 Company Overview

12.12 Apex Biotechnology Corp.

12.12.1 Company Overview

12.13 Smiths Medical

12.13.1 Company Overview

12.13.2 Value Chain Analysis

13 Appendix

13.1 GlobalData Research Methodology

13.2 Coverage

13.3 Secondary Research

13.4 Primary Research

13.5 Models

13.6 Forecasts

13.7 Expert Panel Validation

13.8 Currency Conversion

13.9 Contact Us

13.10 Disclaimer

1.1 List of Tables

Table 1: Medical Device Registration Fee in Brazil, 2002

Table 2: Diabetes Care Devices, Brazil, Overall Revenue ($ m), Historic, 2000-2008

Table 3: Diabetes Care Devices, Brazil, Overall Revenue ($ m), Forecast, 2008-2015

Table 4: Diabetes Care Devices, Brazil, Category Volume (Units), Historic, 2000-2008

Table 5: Diabetes Care Devices, Brazil, Category Volume (Units), Forecast, 2008-2015

Table 6: Diabetes Care Devices, Brazil, Cross-Category Analysis, 2000-2015

Table 7: Diabetes Care Devices, Brazil, Company Share by Revenue ($ m), 2007-2008

Table 8: Glucose Monitoring, Brazil, Revenue ($ m) by Segment, Historic, 2000-2008

Table 9: Glucose Monitoring, Brazil, Revenue ($ m) by Segment, Forecast, 2008-2015

Table 10: Glucose Monitoring, Brazil, Volume (Units) by Segment, Historic, 2000-2008

Table 11: Glucose Monitoring, Brazil, Volume (Units) by Segment, Forecast, 2008-2015

Table 12: Glucose Monitoring, Brazil, Average Price ($), Historic, 2000-2008

Table 13: Glucose Monitoring, Brazil, Average Price ($), Forecast, 2008-2015

Table 14: Glucose Monitoring, Brazil, Distribution Share by Revenue ($ m), 2007-2008

Table 15: Glucose Monitoring, Brazil, Company Share by Revenue ($ m), 2007-2008

Table 16: Insulin Delivery, Brazil, Revenue ($ m) by Segment, Historic, 2000-2008

Table 17: Insulin Delivery, Brazil, Revenue ($ m) by Segment, Forecast, 2008-2015

Table 18: Insulin Pens, Brazil, Revenue ($ m) by Sub-Segment, Historic, 2000-2008

Table 19: Insulin Pens, Brazil, Revenue ($ m) by Sub-Segment, Forecast, 2008-2015

Table 20: Insulin Delivery, Brazil, Volume (Units) by Segment, Historic, 2000-2008

Table 21: Insulin Delivery, Brazil, Volume (Units) by Segment, Forecast, 2008-2015

Table 22: Insulin Pens, Brazil, Volume (Units) by Sub-Segment, Historic, 2000-2008

Table 23: Insulin Pens, Brazil, Volume (Units) by Sub-Segment, Forecast, 2008-2015

Table 24: Insulin Delivery, Brazil, Average Price ($), Historic, 2000-2008

Table 25: Insulin Delivery, Brazil, Average Price ($), Forecast, 2008-2015

Table 26: Insulin Delivery, Brazil, Distribution Share by Revenue ($m), 2007-2008

Table 27: Insulin Delivery, Brazil, Company Share by Revenue ($ mn), 2007-2008

Table 28: F. Hoffmann-La Roche Ltd Pipeline Products by Equipment Type

Table 29: F. Hoffmann-La Roche Ltd Pipeline Products by Development Stage

Table 30: F. Hoffmann-La Roche Ltd Pipeline Products by Therapy Area

Table 31: LifeScan, Inc. Pipeline Products by Equipment Type

Table 32: LifeScan, Inc. Pipeline Products by Development Stage

Table 33: LifeScan, Inc. Pipeline Products by Therapy Area

Table 34: LifeScan, Inc. Pipeline Products by Clinical Trials

Table 35: LifeScan, Inc. Pipeline Products by News Summary

Table 36: Abbott Laboratories Pipeline Products by Equipment Type

Table 37: Abbott Laboratories Pipeline Products by Development Stage

Table 38: Abbott Laboratories Pipeline Products by Therapy Area

Table 39: Abbott Laboratories Pipeline Products by Clinical Trials

Table 40: Abbott Laboratories Pipeline Products by News Summary

Table 41: Bayer HealthCare AG Pipeline Products by Equipment Type

Table 42: Bayer HealthCare AG Pipeline Products by Development Stage

Table 43: Bayer HealthCare AG Pipeline Products by Therapy Area

Table 44: Bayer HealthCare AG Pipeline Products by News Summary

Table 45: Medtronic, Inc. Pipeline Products by Equipment Type

Table 46: Medtronic, Inc. Pipeline Products By Development Stage

Table 47: Medtronic, Inc. Pipeline Products By Therapy Area

Table 48: Medtronic, Inc. Pipeline Products By Clinical Trials

Table 49: Medtronic, Inc. Pipeline Products By News Summary

Table 50: Eli Lilly and Company Pipeline Products by Equipment Type

Table 51: Eli Lilly and Company Pipeline Products by Development Stage

Table 52: Eli Lilly and Company Pipeline Products by Therapy Area

Table 53: Eli Lilly and Company Pipeline Products by Clinical Trials

Table 54: Eli Lilly and Company Pipeline Products by News Summary

Table 55: Novo Nordisk A/S Pipeline Products by Equipment Type

Table 56: Novo Nordisk A/S Pipeline Products By Development Stage

Table 57: Novo Nordisk A/S Pipeline Products By Therapy Area

Table 58: Novo Nordisk A/S Pipeline Products By Clinical Trials

Table 59: USD to Local Currency, Average Exchange Rate 2008

1.2 List of Figures

Figure 1: Health Expenditure by Source in Brazil

Figure 2: Diabetes Care Devices, Brazil, Overall Revenue ($ m), Historic, 2000-2008

Figure 3: Diabetes Care Devices, Brazil, Overall Revenue ($ m), Forecast, 2008-2015

Figure 4: Diabetes Care Devices, Brazil, Category Volume (Units), Historic, 2000-2008

Figure 5: Diabetes Care Devices, Brazil, Category Volume (Units), Forecast, 2008-2015

Figure 6: Diabetes Care Devices, Brazil, Cross-Category Analysis, 2000-2015

Figure 7: Diabetes Care Devices, Brazil, Company Share (%), 2008

Figure 8: Glucose Monitoring, Brazil, Revenue ($ m) by Segment, Historic, 2000-2008

Figure 9: Glucose Monitoring, Brazil, Revenue ($ m) by Segment, Forecast, 2008-2015

Figure 10: Glucose Monitoring, Brazil, Volume (Units) by Segment, Historic, 2000-2008

Figure 11: Glucose Monitoring, Brazil, Volume (Units) by Segment, Forecast, 2008-2015

Figure 12: Glucose Monitoring, Brazil, Company Share (%), 2008

Figure 13: Insulin Delivery, Brazil, Revenue ($ m) by Segment, Historic, 2000-2008

Figure 14: Insulin Delivery, Brazil, Revenue ($ m) by Segment, Forecast, 2008-2015

Figure 15: Insulin Pens, Brazil, Revenue ($ m) by Sub-Segment, Historic, 2000-2008

Figure 16: Insulin Pens, Brazil, Revenue ($ m) by Sub-Segment, Forecast, 2008-2015

Figure 17: Insulin Pens, Brazil, Volume (Units) by Sub-Segment, Historic, 2000-2008

Figure 18: Insulin Pens, Brazil, Volume (Units) by Sub-Segment, Forecast, 2008-2015

Figure 19: Insulin Delivery, Brazil, Company Share (%), 2008

Figure 20: GlobalData Methodology